Clinical Safety

In the high-stakes world of intensive care units (ICUs), severe community-acquired pneumonia (CAP) stands as a formidable adversary, often demanding prolonged hospital stays and extensive resources like ventilatory support, especially among older adults. This condition, contracted outside hospital

The alarming statistic that individuals with type 1 diabetes face a 4.29-fold increased risk of developing bladder cancer has sent ripples through the medical community, challenging long-held assumptions about the intersection of metabolic disorders and malignancies. With bladder cancer already

In a landscape where lung cancer remains one of the most challenging diseases to treat, particularly for rare subsets of patients, a new development has sparked hope among clinicians and affected individuals alike. Bayer’s recently approved drug, sevabertinib, marketed as Hyrnuo, has gained

In a groundbreaking development for rheumatoid arthritis treatment, Lifordi Immunotherapeutics, a clinical-stage biotech firm headquartered in Burlington, Massachusetts, has successfully raised $112 million in a funding round led by Sanofi Ventures, with continued support from prominent investors

In a landscape where mental health crises are increasingly common, a troubling shift in New Zealand's support system has sparked alarm among professionals and advocates, highlighting significant safety concerns. The Public Service Association (PSA) Te Pūkenga Here Tikanga Mahi has voiced strong

In a significant stride for healthcare in South Australia, the recent opening of a cutting-edge medical oncology infusion suite at Western Hospital in Henley Beach has reignited hope and accessibility for cancer patients in the region, marking a pivotal moment for the community. This development,